New MASAC iron guidelines reveal a ‘new normal’ for bleeding disorders

For most of my life, “tired” was the only word I had, and it was never enough.

I’d say it to doctors the way you’d mention the weather — a fact so ordinary it wasn’t worth writing down. And mostly, it wasn’t. Tired was normal. Heavy periods were normal. Being a woman in a body that bled too much and recovered too slowly was, apparently, just the deal.

So I want to tell you about two numbers that turn tired into something a doctor can actually see, because a new set of guidelines just put them on the page.

This spring, the National Bleeding Disorders Foundation‘s Medical and Scientific Advisory Council (MASAC), which has issued treatment recommendations for our community since 1954, released guidance on screening for iron deficiency in people with inherited bleeding disorders. It was published in Haemophilia, and here’s a detail I love: They made it open-access so patients could read it, not just providers. They want us to be able to ask better questions about our own iron. Imagine.

Until now, there was no standard for when or how to check iron levels in this population. Iron deficiency is the most common nutrient deficiency in the world, and people who bleed are at higher risk almost by definition — yet no one had drawn the line for us. Now they have.

The recommendation is refreshingly plain. Everyone with an inherited bleeding disorder should be screened for iron deficiency and anemia at least once a year — every age, both sexes, every level of severity. Not just those with severe hemophilia. Not just the person with dramatic joint bleeds. All of us, including women long waved off as just carriers.

Recommended Reading

June 26, 2026 News by Michela Luciano, PhD

Many US hemophilia treatment centers lack genetic counselors

Raising the numbers

Then there are the thresholds for diagnosing anemia and iron deficiency, and this is the part I’d underline twice.

For adults with inherited bleeding disorders, MASAC recommends a hemoglobin level of less than 13 g/dL as the cutoff for diagnosing anemia. Meanwhile, the World Health Organization defines anemia as hemoglobin less than 12 g/dL in nonpregnant women and less than 13 g/dL in men.

To diagnose iron deficiency, MASAC recommends a ferritin level of less than 50 ng/mL as the cutoff for people of all ages with inherited bleeding disorders. This is higher than the cutoff stamped on most lab reports. As the article notes, “many laboratories still use a female specific cutoff in the 10–13 ng/mL range compared to 30 ng/mL in males.”

Why higher? Because we lose blood more often than the general population, and a “normal” flag calibrated for everyone else can quietly miss us.

My own labs make the point better than I can. My hemoglobin is 12.5 g/dL. My ferritin sits in the 30s ng/mL. On a standard report, both wear that reassuring normal flag — 12.5 clears the hemoglobin cutoff for women, and a ferritin level in the 30s has never made my doctor blink. Hold those same numbers up against the new guidance, though, and the picture flips: 12.5 is less than 13, and the 30s are well under 50. By the standard everyone else is measured against, I’m fine. By the standard built for people who bleed, I’m not. Same blood draw, two different answers. Only one of them was ever going to help me.

An alarming statistic

Here is the statistic that stopped me cold. When MASAC looked at the data, they found that of more than 10,500 women and girls aged 13-40 with bleeding disorders, only 4% had ever been screened for iron deficiency. Of those checked, 72% met the criteria.

Read that again. The majority of the women who finally got tested were iron-deficient, yet only a small percentage were tested. That gap isn’t a rounding error. It’s a generation of exhaustion filed under “normal,” a generation told the fatigue and brain fog and breathlessness on the stairs was just life, just stress, just being a busy woman.

If you take one thing from this, let it be this: At your next doctor visit, ask for a ferritin test, not just a hemoglobin test. Ask for the actual number, and ask where it falls relative to MASAC’s recommendations, not whatever range your lab prints. If you’re told it’s fine, you’re allowed to ask — fine for whom?

Sometimes the most meaningful advances in healthcare don’t come from a new medication or breakthrough therapy. Sometimes they come from recognizing that the old way of measuring health wasn’t telling the whole story. For many of us living with inherited bleeding disorders, that’s a change worth celebrating.

Note: Hemophilia News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Hemophilia News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to hemophilia.